ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Impinj Joins DoseID Consortium to Advance RAIN RFID Use in Healthcare

Impinj-enabled IoT solutions build on vision for better patient care and improved staff safety

Impinj, Inc. (NASDAQ: PI), a leading RAIN RFID provider and Internet of Things pioneer, today announced the company has joined the DoseID Consortium to expand its focus on RAIN radio-frequency identification (RAIN RFID) applications in healthcare, and to participate in developing standards for RAIN RFID healthcare use. DoseID is a member-driven industry consortium with representatives from leading pharmaceutical companies, healthcare providers and hospitals. Impinj shares DoseID’s mission and vision of facilitating industry-wide collaboration for RAIN RFID healthcare standards and use.

Today, Impinj partners with healthcare providers that use its RAIN RFID products to deliver solutions that improve patient care, reduce costs, and increase efficiencies by better managing assets and inventory and by automating systems that keep patients and staff safe. Solutions built by Impinj partners are designed to work within an existing healthcare setting, supporting compliance with procedures and regulations and making the work of caring for patients easier.

“RAIN RFID based solutions in hospitals and healthcare help organizations focus on caring for patients. We are excited to join the DoseID Consortium to help advance their healthcare vision,” said Impinj Vice President of Advanced Technology Megan Brewster. “Our RAIN RFID products help healthcare providers operate with confidence, knowing that systems are in place to automate inventory management, track uniforms and bed linens, streamline patient care and help keep caregivers safe. DoseID enables the healthcare industry to further standardize RAIN RFID use and empowers us to continue inventing.”

“DoseID is pleased that Impinj has joined our consortium to help spread the use of RFID in healthcare to track drug products, instruments, and supplies and improve outcomes,” said Tim Kress-Spatz, President of DoseID. “We look forward to Impinj sharing its knowledge as we further the DoseID specification.”

To learn more about Impinj-enabled solutions for healthcare, visit https://www.impinj.com/industries/healthcare.

About Impinj

Impinj (NASDAQ: PI) helps businesses and people analyze, optimize, and innovate by wirelessly connecting billions of everyday things—such as apparel, automobile parts, luggage, and shipments—to the Internet. The Impinj platform uses RAIN RFID to deliver timely data about these everyday things to business and consumer applications, enabling a boundless Internet of Things. www.impinj.com

Contacts

Jill West

Vice President, Strategic Communications

Phone: +1 206-834-1110

jwest@impinj.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.